Hamm & Wittkopp patent opposition analysis

The comprehensive analysis of Hamm & Wittkopp opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Stay updated with the latest patent oppositions filed by Hamm & Wittkopp

Patent NumberTitleApplicantOpposition DateOpposition Company
Pharmaceutical Composition, Methods For Treating And Uses ThereofBOEHRINGER INGELHEIMSep 16, 2025HAMM & WITTKOPP
Sodium (2R, 5S, 13Ar) -7, 9-Dioxo-10- ( (2,4,6-Trifluorobenzyl) Carbamoyl) -2, 3, 4, 5, 7, 9, 13, 13A-Octahydro-2, 5-Methanopyrido [1',2' : 4.5] Pyrazino [2, 1-B] Oxazepin-8-OlateGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
Pharmaceutical FormulationsGILEAD SCIENCESSep 2, 2025HAMM & WITTKOPP
Processes For Preparing Jak Inhibitors And Related Intermediate CompoundsINCYTEAug 12, 2025HAMM & WITTKOPP
New Use Of A Combination Of An Angiotensin Receptor Blocker (Arb) With A Neutral Endopeptidase Inhibitor (Nepi)NOVARTISJul 23, 2025BETAPHARM ARZNEIMITTEL
Cannabidiol Preparations And Its UsesJAZZ PHARMACEUTICALS RESEARCH UKJul 22, 2025HAMM & WITTKOPP
Methods Of Treating Conditions Related To The S1P1 ReceptorARENA PHARMACEUTICALSJul 15, 2025SYNTHON
Anticancer CompositionsARAGON PHARMACEUTICALSJul 7, 2025HAMM & WITTKOPP
Methods For Dose Initiation Of Aripiprazole TreatmentsOTSUKA PHARMACEUTICALJul 1, 2025STADA ARZNEIMITTEL
Solid State Forms Of Mavacamten And Process For Preparation ThereofASSIA CHEMICAL INDUSTRIESJun 18, 2025HAMM & WITTKOPP